Methods and compositions for modulating hyperstabilized c-met

Details for Australian Patent Application No. 2006229989 (hide)

Owner Genentech, Inc.

Inventors Wickramasinghe, Dineli M.; KongBeltran, Monica

Agent Griffith Hack

Pub. Number AU-B-2006229989

PCT Pub. Number WO2006/104911

Priority 60/665,482 25.03.05 US

Filing date 24 March 2006

Wipo publication date 5 October 2006

Acceptance publication date 2 February 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/104911 Priority application(s): WO2006/104911

2 February 2012 Application Accepted

  Published as AU-B-2006229989

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006229990-C-met mutations in lung cancer

2006229988-Methods and apparatuses for disposition of a medical device onto an elongate medical device